Barclays’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,006
| Closed | -$32K | – | 4641 |
|
|
2025
Q1 | $32K | Sell |
20,006
-49,614
| -71% | -$79.4K | ﹤0.01% | 3984 |
|
|
2024
Q4 | $198K | Buy |
69,620
+11,731
| +20% | +$33.4K | ﹤0.01% | 3527 |
|
|
2024
Q3 | $226K | Buy |
57,889
+15,551
| +37% | +$60.7K | ﹤0.01% | 3417 |
|
|
2024
Q2 | $340K | Buy |
+42,338
| New | +$340K | ﹤0.01% | 2751 |
|